[1]
A. Hammoudeh, “Adherence to clinical practice guidelines and use of secondary cardiovascular prevention medications in Middle Eastern patients undergoing percutaneous coronary intervention: Results from The First Jordanian PCI Registry (JoPCR1)”, JMJ, vol. 53, no. 3, Feb. 2016.